Supernus Pharmaceuticals | SUPN - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Abbott USD 2.39B 27M 2026-03
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Aurora Cannabis CAD 11.41M 12.99M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Canopy Growth CAD -157.96M 95.71M 2026-03
Cara Therapeutics USD -4.91M 3.17M 2025-03
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Eisai JPY -7.94B 29.94B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Novo Nordisk DKK 33.8B 3.23B 2025-06
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
United Therapeutics USD 444M 6M 2025-12
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03